A detailed history of Triumph Capital Management transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Triumph Capital Management holds 14,675 shares of SANA stock, worth $45,492. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,675
Previous 21,675 32.3%
Holding current value
$45,492
Previous $36,000 11.11%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

SELL
$1.34 - $2.97 $9,380 - $20,790
-7,000 Reduced 32.3%
14,675 $40,000
Q1 2025

May 06, 2025

BUY
$1.65 - $4.3 $35,763 - $93,202
21,675 New
21,675 $36,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $590M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Triumph Capital Management Portfolio

Follow Triumph Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triumph Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Triumph Capital Management with notifications on news.